Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Positron-Emission Tomography Enhancers
- Molecular classification
- Radiotracer, Radiopharmaceutical
01
Overview
Positron-emission tomography (PET) enhancers are not a single molecule or receptor, but rather refer to agents—primarily radiotracers or radiopharmaceuticals—that enhance the imaging capabilities of PET scans. These agents are designed to improve the visualization and quantification of metabolic, biochemical, or molecular processes in tissues and organs during PET imaging. They act as "enhancers" by targeting specific physiological pathways or receptors relevant to disease processes such as cancer, neurological disorders, or cardiovascular disease. Common examples include 18F-fluorodeoxyglucose (FDG), 18F-sodium fluoride, 15O-water, 11C-methionine, and 18F-fluoroestradiol.
- Other names
- PET TracersRadiotracers for PET ImagingRadiopharmaceuticals for PET Imaging
02
Mechanism of action
Emit positrons after administration; enable detection via annihilation photon pairs
03
Biological functions
Visualization of tissue metabolismAssessment of blood flowEvaluation of neurotransmitter activityTumor detection and monitoring
04
Disease associations
CancerNeurological disordersCardiovascular disease
05
Safety considerations
Radiation exposureShort half-life requiring on-site synthesis
Beyond the preview
Go deeper on Positron-Emission Tomography Enhancers.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Positron-Emission Tomography Enhancers.